about
Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?Investigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic Systems.Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.Role of nitric oxide in motor control: implications for Parkinson's disease pathophysiology and treatment.Nitric oxide, a new player in L-DOPA-induced dyskinesia?Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats.Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models.Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.Regulation of Striatal Neuron Activity by Cyclic Nucleotide Signaling and Phosphodiesterase Inhibition: Implications for the Treatment of Parkinson's Disease.Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression.Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease.Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of l-DOPA-induced dyskinesia in 6-OHDA-lesioned ratsRepurposing an established drug: an emerging role for methylene blue in L-DOPA-induced dyskinesiaAge- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease
P50
Q27324133-4E988CCF-8841-4F71-BB9C-8CA283DAA79DQ34440714-5A752A3C-E965-45D3-B0F4-248328F439ABQ35307838-9A5541DF-6ED3-4C68-907C-4B9E80F191DEQ37849788-9C407770-A614-42EC-A6F9-0D4B6703ADA1Q38305163-2E31E68E-88D6-4C9D-94FE-3EFAAE641D4DQ42755842-23259D8F-D1B9-4DF7-ACDB-8126262B2145Q42800140-74B692B3-F05E-4371-8E12-263EE8E35B1CQ44738958-E891B2F3-54F7-45BF-9A7D-CA21D8DC4621Q45299354-7DBD8ADB-4A6B-424D-9506-5A49AF1DA017Q46080337-F0F4C9E1-ADF0-4AC1-8BDB-17E82E670FECQ47909580-BC0ADC22-0962-4D9A-824C-D505C1D0656BQ48154542-8E3EB9A8-7285-4944-9D1E-C18523B8978AQ48329232-E5720144-7419-4EF3-86E9-708621DF6E02Q51030742-C402EBD3-8BD9-489D-89DB-A3DF904CF09AQ62272723-9B9F7BA5-BCC2-44F7-9C8D-E8920DA62953Q64865053-B580F4E1-E43B-48A1-952F-BE43581498DDQ90355093-014CDB0D-2521-46D0-83B8-F063B1B67CA9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fernando Eduardo Padovan-Neto
@ast
Fernando Eduardo Padovan-Neto
@en
Fernando Eduardo Padovan-Neto
@es
Fernando Eduardo Padovan-Neto
@nl
Fernando Eduardo Padovan-Neto
@sl
type
label
Fernando Eduardo Padovan-Neto
@ast
Fernando Eduardo Padovan-Neto
@en
Fernando Eduardo Padovan-Neto
@es
Fernando Eduardo Padovan-Neto
@nl
Fernando Eduardo Padovan-Neto
@sl
altLabel
F E Padovan-Neto
@en
prefLabel
Fernando Eduardo Padovan-Neto
@ast
Fernando Eduardo Padovan-Neto
@en
Fernando Eduardo Padovan-Neto
@es
Fernando Eduardo Padovan-Neto
@nl
Fernando Eduardo Padovan-Neto
@sl
P1053
G-6655-2012
P106
P1153
8523997100
P21
P31
P3829
P4012
P496
0000-0002-5529-3168